FBInvestor
Stocks / Newamsterdam Pharma Company
Institutional Ownership

Newamsterdam Pharma Company

CUSIP N62509109ORDINARY SHARESQ1 2026

13D / 13G Filings
36
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
11.3%
Max % of class reported
Institutional Holders
165
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

36 filings · latest Feb 17, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 17, 2026Viking Global Investors LP13G/A3.7%4.20MSEC
2Feb 5, 2026Fmr LLC13G5.7%6.41MSEC
3Dec 4, 2025Bcls Fund III Investments, LP13D/A4.7%SEC
4Nov 13, 2025Capital World Investors13G/A8.7%9.82MSEC
5Nov 7, 2025Bcls Fund III Investments, LP13D/A10.0%SEC
6Nov 4, 2025Frazier Life Sciences X, L.P.13D/A7.7%SEC
7Sep 30, 2025Forbion Capital Fund IV Cooperatief U.A.13D/A8.3%SEC
8Aug 20, 2025Frazier Life Sciences X, L.P.13D/A6.5%SEC
9Aug 13, 2025Capital World Investors13G/A7.5%8.39MSEC
10Aug 12, 2025Forbion Capital Fund IV Cooperatief U.A.13D/A9.4%SEC

26 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Newamsterdam Pharma Company.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →